MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
2513.41%
Quick Ratio
2513.41%
Cash Ratio
2424.20%
Debt to Asset Ratio
4.26%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Short-term investments
    • Long-term investments
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liability long ...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
225,491,985
79,250,163
93,928,566
15,947,308
Short-term investments
6,615,168
11,328,999
6,480,860
-
Prepaid expenses and other current assets
1,682,918
1,695,649
828,329
636,972
Total current assets
233,790,071
92,274,811
101,237,755
16,584,280
Other assets
20,418
20,418
20,418
20,418
Deferred offering costs
-
164,723
93,630
111,689
Long-term investments
2,052,142
-
-
-
Right-of-use assets, net
887,837
927,728
966,917
1,005,434
Property and equipment, net
2,358,428
2,428,377
2,521,621
2,358,783
Total assets
239,108,896
95,816,057
104,840,341
20,080,604
Accounts payable and accrued expenses
9,190,591
10,414,266
9,971,207
10,709,299
Operating lease liability - current
111,114
125,392
139,339
141,282
Total current liabilities
9,301,705
10,539,658
10,110,546
10,850,581
Operating lease liability long term
890,638
912,343
933,625
965,053
Total liabilities
10,192,343
11,452,001
11,044,171
11,815,634
Common stock, 0.0001 par value 200,000,000 shares authorized 71,608,042 shares issued and 71,535,679 shares outstanding at june 30, 2026 and 53,023,466 shares issued and 52,951,103 shares outstanding at december 31, 2025
7,160
5,307
5,301
3,311
Additional paid-in capital
354,997,609
198,903,047
198,293,956
102,074,612
Accumulated other comprehensive income
118,720
105,636
60,160
62,464
Accumulated deficit
-126,106,973
-114,549,971
-104,463,284
-93,775,454
Treasury stock at cost, 72,363 shares as of june 30, 2026 and december 31, 2025
99,963
99,963
99,963
99,963
Total stockholders equity
228,916,553
84,364,056
93,796,170
8,264,970
Total liabilities and stockholders equity
239,108,896
95,816,057
104,840,341
20,080,604
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$225,491,985 (1837.56%↑ Y/Y)Short-term investments$6,615,168 Prepaid expenses andother current assets$1,682,918 (144.78%↑ Y/Y)Total current assets$233,790,071 (1796.81%↑ Y/Y)Property and equipment,net$2,358,428 (5.69%↑ Y/Y)Long-term investments$2,052,142 Right-of-use assets, net$887,837 (-6.26%↓ Y/Y)Other assets$20,418 (0.00%↑ Y/Y)Total assets$239,108,896 (1429.31%↑ Y/Y)Total liabilities andstockholders equity$239,108,896 (1429.31%↑ Y/Y)Total stockholdersequity$228,916,553 (4819.73%↑ Y/Y)Total liabilities$10,192,343 (-7.19%↓ Y/Y)Accumulated deficit-$126,106,973 (-46.31%↓ Y/Y)Treasury stock at cost,72,363 shares as of june...$99,963 (0.00%↑ Y/Y)Additional paid-in capital$354,997,609 (290.64%↑ Y/Y)Total currentliabilities$9,301,705 (-7.07%↓ Y/Y)Operating lease liability long term$890,638 (-8.40%↓ Y/Y)Accumulated othercomprehensive income$118,720 (82.56%↑ Y/Y)Common stock, 0.0001par value...$7,160 (151.49%↑ Y/Y)Accounts payable andaccrued expenses$9,190,591 (-7.53%↓ Y/Y)Operating lease liability- current$111,114 (57.68%↑ Y/Y)

Immix Biopharma, Inc. (IMMX)

Immix Biopharma, Inc. (IMMX)